Innovation, RxSafe announce distribution partnership
JOHNSON CITY, N.Y. — A new agreement between Innovation and RxSafe allows Innovation to distribute RxSafe’s line of automated, high-density robotic storage and retrieval systems for pharmacies, the two companies said.
Innovation makes the PharmASSIST line of pharmacy automation products, while RxSafe makes the RxSafe and RxVault systems.
"The RxSafe product line perfectly complements our PharmASSIST product suite and enables us to offer our customers the ability to automate up to 100% of their prescription volume," Innovation EVP global business development Doyle Jensen said. "We can now truly scale to the customer’s full range of prescription fulfillment needs and grow with them in all areas."
RxSafe’s technology is designed to automatically and securely store, retrieve and track pharmacy inventory down to the pill or package, handling pharmacy inventory in native packaging.
"Our partnership with Innovation takes full advantage of the considerable talent and technical strengths of both companies," RxSafe CEO William Holmes said. "We are thrilled that Innovation, with its global sales and service outreach, will be distributing our RxSafe product line."
Both companies will share Booth #782 at the National Association of Chain Drug Stores’ Pharmacy & Technology Conference in Boston, which will take place from Aug. 27-30.
Physical inactivity, Type 2 diabetes linked in new research
NEW YORK — Physical inactivity may play a key role in the development of Type 2 diabetes, according to new research.
John Thyfault, an assistant professor at the University of Missouri’s departments of nutrition and exercise physiology and internal medicine, studied the relationship between low levels of physical activity and elevated levels of postprandial glucose, which refers to the spikes in blood sugar that occur after a meal. PPG, which has been associated with increased incidences of cardiovascular disease and death, also is a risk factor for the development of Type 2 diabetes. What Thyfault found while monitoring activity levels and diets of healthy and moderately active young adults, was that those people that reduced their physical activity by about half for three days saw their PPG responses to meals double.
"We now have evidence that physical activity is an important part of the daily maintenance of glucose levels," Thyfault said. "Even in the short term, reducing daily activity and ceasing regular exercise causes acute changes in the body associated with diabetes that can occur before weight gain and the development of obesity.
"This study shows that physical activity directly impacts health issues that are preventable," he concluded.
The study is being published in Medicine & Science in Sports & Exercise.
New SoloHealth kiosks to use latest Intel technology
NEW YORK — The next generation of health kiosks made by SoloHealth will use the latest technologies from Intel, the company said.
The SoloHealth Station — which measures blood pressure, vision, weight and body mass index — will use an Intel Core i5 processor-based computer and deliver an interactive, secure and networked experience for consumers. It also will allow easy repairs and adjustments that can be made from one centralized computer.
SoloHealth developed the SoloHealth Station, currently in a test program with an unspecified nationwide retailer, under a partnership with Intel.
The company, which will be at the National Association of Chain Drug Stores’ Pharmacy & Technology Conference in Boston starting Saturday, said it also was in talks with drug, mass merchandise and grocery chains around the country, as well as healthcare providers and businesses, to deploy the SoloHealth Station at more locations.
Intel recently released a case study on the kiosks, available here.